Clinical Role - Payer

Pharmacy Times® is a leader in providing the latest clinical updates, patient counseling tools and innovative solutions to payers, pharmacy benefit managers, formulary chairs and directors, managed care directors, quality assurance directors, and Medicaid/Medicare directors.

The report projects changes in upcoming health care markets, including kidney care, digital health, drug cost transparency, the loneliness epidemic, and the self-care market.
Closed-Loop System
Girish Dighe, PharmD, MS, explains the importance of change management within a closed-loop system. 
Safety net providers, which historically work in underserved communities, have successfully petitioned state legislatures to take action on 340B 2-tier pricing.
Although there are many great benefits of mail-order pharmacy, there are times when it may not be the right choice. 
Counties in Medicaid expansion states saw an 11% lower rate of heroin deaths and a 10% lower rate of deaths involving synthetic opioids compared with counties in non-expansion states.
Lower-priced versions of Humalog Mix75/25 KwikPen and Humalog Junior KwikPen will be available in mid-April and will have 50% lower list prices compared with branded versions.
The proposal, which is still largely conceptual, was a part of Newsom’s proposed 2020-2021 budget.1
The Supreme Court released their decision to review Rutledge v. Pharmaceutical Care Management Association, which could affect pharmacy benefits across the country.
There are some basic tips or tricks to getting the most out of your insurance plan and to maintain the care patients are accustomed to.
Manufacturers have selected AllianceRx Walgreens as their limited distribution drug partner for drugs that treat conditions such as myelofibrosis, cystic fibrosis, and non-metastatic castration-resistant prostate cancer.
revenue integrity
Girish Dighe, PharmD, MS, explains why it's important to understand more than just the revenue integrity piece of the puzzle. 
Alternative IVIG Dosing Methods
A study found that intravenous immune globulin dosing optimization through alternative dosing weights represents a significant source of waste reduction and cost reduction.